Search

Home > WSJ What's News > Can ‘Biosimilars’ Shake Up the U.S. Drug Market?
Podcast: WSJ What's News
Episode:

Can ‘Biosimilars’ Shake Up the U.S. Drug Market?
Category: Business
Duration: 00:16:46
Publish Date: 2023-02-01 10:47:00
Description:

A.M. Edition for Feb. 1. One of America’s biggest-selling prescription drugs, AbbVie’s arthritis therapy Humira, is now facing its first competition in the U.S. in the form of a near-identical treatment from Amgen. WSJ health business editor Jonathan Rockoff explains how “biosimilar” drugs work and their potential to drive down prices for insurers and patients. Plus, why Ukraine hasn’t been a boon to U.S. defense companies. Luke Vargas hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices
Total Play: 0

Users also like

3K+ Episodes
All Ears Eng .. 21K+     1K+
700+ Episodes
バイリン .. 13K+     500+
1K+ Episodes
Freakonomics .. 2K+     100+

Some more Podcasts by The Wall Street Journal

200+ Episodes
WSJ Secrets .. 50+     1
20+ Episodes
WSJ Minute B .. 70+     1
1K+ Episodes
WSJ Your Mon .. 10+     3
1K+ Episodes
WSJ Opinion: .. 600+     90+
300+ Episodes
WSJ The Futu .. 40+     10+
3K+ Episodes
WSJ Tech New .. 20+     20+
1K+ Episodes
The Journal.     3
2K+ Episodes
WSJ What’s ..     6